{"DataElement":{"publicId":"7095180","version":"1","preferredName":"Breast Cancer AJCC Edition 8 Clinical Regional Lymph Node N Category","preferredDefinition":"Extent of the regional lymph node involvement for breast carcinoma based on information obtained from the date of cancer diagnosis until the start of definitive treatment, or within four months (whichever is shorter), using AJCC Ed. 8 criteria.","longName":"AJBR202C","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"7095172","version":"1","preferredName":"Questionnaire Domain Breast Neoplasm Clinical N Category","preferredDefinition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to questionnaire._One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest._A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity._One criteria of the TNM staging system. N refers to the extent of lymph node involvement.","longName":"6607890v1.0:7095170v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"6607890","version":"1","preferredName":"Questionnaire Domain","preferredDefinition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to questionnaire.","longName":"C49609","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Questionnaire Domain","conceptCode":"C49609","definition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to questionnaire.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7F1D6CF4-BA8C-2E63-E053-F662850A5BE1","latestVersionIndicator":"Yes","beginDate":"2019-01-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-01-10","modifiedBy":"ONEDATA","dateModified":"2019-01-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"7095170","version":"1","preferredName":"Breast Neoplasm Clinical N Category","preferredDefinition":"One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest.:A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.:Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.:One criteria of the TNM staging system. N refers to the extent of lymph node involvement.","longName":"C12971:C3262:C25398:C25580","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast","conceptCode":"C12971","definition":"One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Clinical","conceptCode":"C25398","definition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"N Category","conceptCode":"C25580","definition":"One criteria of the TNM staging system. N refers to the extent of lymph node involvement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"99FD26FD-48C3-1BF5-E053-F662850AFC44","latestVersionIndicator":"Yes","beginDate":"2019-12-18","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-12-18","modifiedBy":"ONEDATA","dateModified":"2019-12-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435019","version":"1","preferredName":"Conceptual Entity","preferredDefinition":"An organizational header for concepts representing mostly abstract entities.","longName":"C20181","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D8-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NCI CRF Standards","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"99FD26FD-48D4-1BF5-E053-F662850AFC44","latestVersionIndicator":"Yes","beginDate":"2019-12-18","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-12-18","modifiedBy":"HARTLEYG","dateModified":"2020-06-17","changeDescription":"Created for CDSIC aligned NCI Standard CRFs. wz","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6005653","version":"1","preferredName":"Breast Carcinoma American Joint Committee on Cancer Edition 8 Clinical N Category","preferredDefinition":"A clinical finding about one or more characteristics of breast cancer, following the rules of the TNM AJCC v8 classification system as they pertain to staging of regional lymph nodes._A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications._One criteria of the TNM staging system.  N refers to the extent of lymph node involvement._A grouping of items based on some commonality or by user defined characteristics.","longName":"6005653v1.0","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"3","maxLength":"5","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"cN0","valueDescription":"Breast Cancer cN0 TNM Finding v8","ValueMeaning":{"publicId":"6005657","version":"1","preferredName":"Breast Cancer cN0 TNM Finding v8","longName":"6005657","preferredDefinition":"Breast cancer with no regional lymph node metastases (by imaging or clinical examination). (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer cN0 TNM Finding v8","conceptCode":"C139398","definition":"Breast cancer with no regional lymph node metastases (by imaging or clinical examination). (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5BE92707-6066-0ACA-E053-F662850A68BD","latestVersionIndicator":"Yes","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6286292B-AB40-34BC-E053-F662850A4D6D","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-01-11","modifiedBy":"ONEDATA","dateModified":"2018-01-11","deletedIndicator":"No"},{"value":"cN1","valueDescription":"Breast Cancer cN1 TNM Finding v8","ValueMeaning":{"publicId":"6005655","version":"1","preferredName":"Breast Cancer cN1 TNM Finding v8","longName":"6005655","preferredDefinition":"Breast cancer with metastasis to movable ipsilateral level I, II axillary lymph node(s). (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer cN1 TNM Finding v8","conceptCode":"C139399","definition":"Breast cancer with metastasis to movable ipsilateral level I, II axillary lymph node(s). (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5BE92707-6040-0ACA-E053-F662850A68BD","latestVersionIndicator":"Yes","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6286292B-AB54-34BC-E053-F662850A4D6D","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-01-11","modifiedBy":"ONEDATA","dateModified":"2018-01-11","deletedIndicator":"No"},{"value":"cN1mi","valueDescription":"Breast Cancer cN1mi TNM Finding v8","ValueMeaning":{"publicId":"6030873","version":"1","preferredName":"Breast Cancer cN1mi TNM Finding v8","longName":"6030873","preferredDefinition":"Breast cancer with micrometastases (approximately 200 cells, larger than 0.2 mm, but none larger than 2.0 mm). cN1mi is rarely used but may be appropriate in cases where sentinel node biopsy is performed before tumor resection, most likely to occur in cases treated with neoadjuvant therapy. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer cN1mi TNM Finding v8","conceptCode":"C139400","definition":"Breast cancer with micrometastases (approximately 200 cells, larger than 0.2 mm, but none larger than 2.0 mm). cN1mi is rarely used but may be appropriate in cases where sentinel node biopsy is performed before tumor resection, most likely to occur in cases treated with neoadjuvant therapy. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5E7E812B-97E5-1A54-E053-F662850A1346","latestVersionIndicator":"Yes","beginDate":"2017-11-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-11-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6286292B-AB68-34BC-E053-F662850A4D6D","beginDate":"2017-11-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-01-11","modifiedBy":"ONEDATA","dateModified":"2018-01-11","deletedIndicator":"No"},{"value":"cN2","valueDescription":"Breast Cancer cN2 TNM Finding v8","ValueMeaning":{"publicId":"6005684","version":"1","preferredName":"Breast Cancer cN2 TNM Finding v8","longName":"6005684","preferredDefinition":"Breast cancer with metastases in ipsilateral level I, II axillary lymph nodes that are clinically fixed or matted; or in ipsilateral internal mammary nodes in the absence of axillary lymph node metastases. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer cN2 TNM Finding v8","conceptCode":"C139401","definition":"Breast cancer with metastases in ipsilateral level I, II axillary lymph nodes that are clinically fixed or matted; or in ipsilateral internal mammary nodes in the absence of axillary lymph node metastases. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5BE87B52-2BD1-1919-E053-F662850A22E2","latestVersionIndicator":"Yes","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6286292B-AB7C-34BC-E053-F662850A4D6D","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-01-11","modifiedBy":"ONEDATA","dateModified":"2018-01-11","deletedIndicator":"No"},{"value":"cN2a","valueDescription":"Breast Cancer cN2a TNM Finding v8","ValueMeaning":{"publicId":"6005682","version":"1","preferredName":"Breast Cancer cN2a TNM Finding v8","longName":"6005682","preferredDefinition":"Breast cancer with metastases in ipsilateral level I, II axillary lymph nodes fixed to one another (matted) or to other structures. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer cN2a TNM Finding v8","conceptCode":"C139402","definition":"Breast cancer with metastases in ipsilateral level I, II axillary lymph nodes fixed to one another (matted) or to other structures. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5BE87B52-2BAB-1919-E053-F662850A22E2","latestVersionIndicator":"Yes","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6286292B-AB90-34BC-E053-F662850A4D6D","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-01-11","modifiedBy":"ONEDATA","dateModified":"2018-01-11","deletedIndicator":"No"},{"value":"cN2b","valueDescription":"Breast Cancer cN2b TNM Finding v8","ValueMeaning":{"publicId":"6005680","version":"1","preferredName":"Breast Cancer cN2b TNM Finding v8","longName":"6005680","preferredDefinition":"Breast cancer with metastases only in ipsilateral internal mammary nodes in the absence of axillary lymph node metastases. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer cN2b TNM Finding v8","conceptCode":"C139403","definition":"Breast cancer with metastases only in ipsilateral internal mammary nodes in the absence of axillary lymph node metastases. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5BE87B52-2B85-1919-E053-F662850A22E2","latestVersionIndicator":"Yes","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6286292B-ABA4-34BC-E053-F662850A4D6D","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-01-11","modifiedBy":"ONEDATA","dateModified":"2018-01-11","deletedIndicator":"No"},{"value":"cN3","valueDescription":"Breast Cancer cN3 TNM Finding v8","ValueMeaning":{"publicId":"6005678","version":"1","preferredName":"Breast Cancer cN3 TNM Finding v8","longName":"6005678","preferredDefinition":"Breast cancer with metastases in ipsilateral infraclavicular (level III axillary) lymph node(s) with or without level I, II axillary lymph node involvement; or in ipsilateral internal mammary lymph node(s) with level I, II axillary lymph node metastases; or metastases in ipsilateral supraclavicular lymph node(s) with or without axillary or internal mammary lymph node involvement. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer cN3 TNM Finding v8","conceptCode":"C139404","definition":"Breast cancer with metastases in ipsilateral infraclavicular (level III axillary) lymph node(s) with or without level I, II axillary lymph node involvement; or in ipsilateral internal mammary lymph node(s) with level I, II axillary lymph node metastases; or metastases in ipsilateral supraclavicular lymph node(s) with or without axillary or internal mammary lymph node involvement. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5BE87B52-2B5F-1919-E053-F662850A22E2","latestVersionIndicator":"Yes","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6286292B-ABB8-34BC-E053-F662850A4D6D","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-01-11","modifiedBy":"ONEDATA","dateModified":"2018-01-11","deletedIndicator":"No"},{"value":"cN3a","valueDescription":"Breast Cancer cN3a TNM Finding v8","ValueMeaning":{"publicId":"6005676","version":"1","preferredName":"Breast Cancer cN3a TNM Finding v8","longName":"6005676","preferredDefinition":"Breast cancer with metastases in ipsilateral infraclavicular lymph node(s). (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer cN3a TNM Finding v8","conceptCode":"C139405","definition":"Breast cancer with metastases in ipsilateral infraclavicular lymph node(s). (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5BE87B52-2B39-1919-E053-F662850A22E2","latestVersionIndicator":"Yes","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6286292B-ABCC-34BC-E053-F662850A4D6D","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-01-11","modifiedBy":"ONEDATA","dateModified":"2018-01-11","deletedIndicator":"No"},{"value":"cN3b","valueDescription":"Breast Cancer cN3b TNM Finding v8","ValueMeaning":{"publicId":"6005674","version":"1","preferredName":"Breast Cancer cN3b TNM Finding v8","longName":"6005674","preferredDefinition":"Breast cancer with metastases in ipsilateral internal mammary lymph node(s) and axillary lymph node(s). (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer cN3b TNM Finding v8","conceptCode":"C139406","definition":"Breast cancer with metastases in ipsilateral internal mammary lymph node(s) and axillary lymph node(s). (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5BE87B52-2B13-1919-E053-F662850A22E2","latestVersionIndicator":"Yes","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6286292B-ABE0-34BC-E053-F662850A4D6D","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-01-11","modifiedBy":"ONEDATA","dateModified":"2018-01-11","deletedIndicator":"No"},{"value":"cN3c","valueDescription":"Breast Cancer cN3c TNM Finding v8","ValueMeaning":{"publicId":"6005672","version":"1","preferredName":"Breast Cancer cN3c TNM Finding v8","longName":"6005672","preferredDefinition":"Breast cancer with metastases in ipsilateral supraclavicular lymph node(s). (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer cN3c TNM Finding v8","conceptCode":"C139407","definition":"Breast cancer with metastases in ipsilateral supraclavicular lymph node(s). (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5BE87B52-2AED-1919-E053-F662850A22E2","latestVersionIndicator":"Yes","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6286292B-ABF4-34BC-E053-F662850A4D6D","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-01-11","modifiedBy":"ONEDATA","dateModified":"2018-01-11","deletedIndicator":"No"},{"value":"cNX","valueDescription":"Breast Cancer cNX TNM Finding v8","ValueMeaning":{"publicId":"6005659","version":"1","preferredName":"Breast Cancer cNX TNM Finding v8","longName":"6005659","preferredDefinition":"Breast cancer in which regional lymph nodes cannot be assessed (e.g., previously removed). The cNX category is used sparingly in cases where regional lymph nodes have previously been surgically removed or where there is no documentation of physical examination of the axilla. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer cNX TNM Finding v8","conceptCode":"C139397","definition":"Breast cancer in which regional lymph nodes cannot be assessed (e.g., previously removed). The cNX category is used sparingly in cases where regional lymph nodes have previously been surgically removed or where there is no documentation of physical examination of the axilla. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5BE92707-608C-0ACA-E053-F662850A68BD","latestVersionIndicator":"Yes","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6286292B-AC08-34BC-E053-F662850A4D6D","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-01-11","modifiedBy":"ONEDATA","dateModified":"2018-01-11","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6356798","version":"1","preferredName":"Breast Cancer Clinical Regional Lymph Nodes TNM Finding v8 American Joint Committee on Cancer N Category Category","preferredDefinition":"A clinical finding about one or more characteristics of breast cancer, following the rules of the TNM AJCC v8 classification system as they pertain to staging of regional lymph nodes.:A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.:One criteria of the TNM staging system. N refers to the extent of lymph node involvement.:A grouping of items based on some commonality or by user defined characteristics.","longName":"C139396:C39315:C25580:C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer Clinical Regional Lymph Nodes TNM Finding v8","conceptCode":"C139396","definition":"A clinical finding about one or more characteristics of breast cancer, following the rules of the TNM AJCC v8 classification system as they pertain to staging of regional lymph nodes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"American Joint Committee on Cancer","conceptCode":"C39315","definition":"A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"N Category","conceptCode":"C25580","definition":"One criteria of the TNM staging system. N refers to the extent of lymph node involvement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"71357C17-2864-10C0-E053-F662850A51FC","latestVersionIndicator":"Yes","beginDate":"2018-07-17","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-07-17","modifiedBy":"ONEDATA","dateModified":"2018-07-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"5BE85DD7-D5A6-1201-E053-F662850AEE4C","latestVersionIndicator":"Yes","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-19","modifiedBy":"TAYLORT","dateModified":"2019-05-03","changeDescription":"5-3-19 released; tmt. 7/17/18 tt updated/Focus Group recommendations. 11/17/17 tt associated with CS/CSI. 10/19/77 tt curated for standardization; supercedes VD 3419239.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"6921971","version":"1","longName":"CDISC Aligned Collection CDEs","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"7318369","version":"1","longName":"AJCC ED.8, Breast - CDISC Aligned","context":"NCI Standards"},{"publicId":"7318368","version":"1","longName":"Staging/Extent of Disease - CDISC Aligned","context":"NCI Standards"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"CDISC Aligned NCI Standard Equivalent CDE","type":"CDISC Note","description":"This data element is to be used for CDISC aligned data collection in place of CDE 5985727 from the original NCI Standard CRF Template.","url":null,"context":"NCI Standards"},{"name":"Clinical N category","type":"Preferred Question Text","description":"Clinical N category","url":null,"context":"NCI Standards"}],"origin":"NCI CRF Standards","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"99FD368D-1A56-1BF9-E053-F662850AAA07","latestVersionIndicator":"Yes","beginDate":"2019-12-18","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-12-18","modifiedBy":"GDEEN","dateModified":"2023-02-13","changeDescription":"CDISC Aligned NCI Standard Template Text","administrativeNotes":"02.13.23_Set Reg Status to Standard for all CDISC Aligned content_ghd","unresolvedIssues":null,"deletedIndicator":"No"}}